Is coronavirus really mutating to become more dangerous?
Some scientists suggest changes are making the Covid-19 virus more virulent
Scientists have discovered that the new coronavirus has mutated several times - but experts are divided over whether the new variants pose more of a threat.
The spread of one mutation in particular “is worrying”, says Bette Korber, a computational biologist who led a study of the new coronavirus at the New Mexico-based Los Alamos National Laboratory.
Korber and her team report “a mutated form of the virus very rapidly emerging, and over the month of March becoming the dominant pandemic form”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Another study, at University College London, “identified 198 recurring mutations”, reports the BBC. However, the researchers said there was no evidence that any of the mutations had changed the behaviour of the Sars-CoV-2 virus in any significant way.
“Mutations in themselves are not a bad thing,” said Professor Francois Balloux. “So far, we cannot say whether Sars-CoV-2 is becoming more or less lethal and contagious.”
Why do viruses mutate?
“Mutations are tiny changes to genetic material that occur as it is copied,” says The New York Times. These changes occur at random and most “have little effect”, but sometimes a change will allow the new variant of the virus to spread more easily - or make it more deadly.
While mutations are common, the emergence of a new strain of a virus is more unusual.
Although there’s “no clear, fixed threshold” for what constitutes the latter, “the term has the same connotation in virology as it does colloquially - it implies importance”, says The Atlantic. “Viruses change all the time; strains arise when they change in meaningful ways.”
Has the Covid-19 coronavirus developed different strains?
Apparently not. “The coronavirus is actually quite stable,” says The Guardian’s science editor Ian Sample. “Scientists have analysed about 13,000 samples in Britain since mid-March and found that new mutations appear roughly twice a month.”
Researchers at the University of Glasgow concluded that the mutations identified so far “did not amount to different strains of the virus”, the BBC reports. “They concluded that only one type of the virus is currently circulating.”
Previous coronaviruses have also changed slowly, mutating “at a tenth of the speed” of the flu virus, says The Atlantic.
Is the virus different in each country?
The new coronavirus has mutated as it has spread across the world, and different variants have taken root in different places.
“Researchers in Germany identified three main genetic groups of the virus in April, which they named A, B and C,” says The Guardian’s Sample. “Groups A and C are mostly found in Europeans and Americans, while group B is most common in East Asia.”
The team behind the Los Alamos study have suggested that a more virulent form of the virus, known as Spike D614G, “began spreading in Europe in early February”, reaching the US soon after.
In a research paper outlining their findings, the researchers say that the prevalence of this strain “is increasing in frequency at an alarming rate, indicating a fitness advantage relative to the original Wuhan strain that enables more rapid spread”.
However, other virologists told The Atlantic that “the paper’s claims are plausible, but not justified by the evidence it presents”. The spread of Spike D614G might also be the result of China’s comprehensive lockdown, which trapped other variants within the country’s borders, these critics argue.
Martin Hibberd, a professor of emerging infectious diseases at the London School of Hygiene and Tropical Medicine, told The Guardian that more research was needed to “reveal whether the new mutations help [the virus] spread and whether vaccines may need to be redesigned”.
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Start your trial subscription today –––––––––––––––––––––––––––––––
Why might vaccines be affected?
The rapidly mutating flu virus requires a new vaccine every year, because antibodies that can fight one strain of influenza may be ineffective against another. By contrast, the stability of the new coronavirus has led scientists working on a Covid-19 vaccine to hope that a single dose might offer long-term protection.
“The Los Alamos report could upend that assumption,” says the Los Angeles Times. “The virus could undergo further mutations even as research organisations prepare the first medical treatments and vaccines… [and] the effectiveness of vaccines could be limited.”
However, there is no evidence that this has happened yet, adds The New York Times, which points out that “unlike the flu, the coronavirus so far has not split into clearly distinct forms”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Saint Paul de Vence: a paradise for art lovers
The Week Recommends The hilltop gem in the French Riviera where 20th century modernism flourished
By Alexandra Zagalsky Published
-
'People in general want workers to earn a decent living'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
What might a Trump victory mean for the global economy?
Today's Big Question A second term in office for the 'America First' administration would send shockwaves far beyond the United States' shores
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
A 'transformative' gene therapy for haemophilia B
The Explainer Costly treatment that could be 'truly life-changing' for patients with rare blood disorder gets funding boost
By Julia O'Driscoll, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published